Ferah, S. Et Al. 2023. Fisetin additively affects the Temozolomide response of Glioblastoma cells under normoxia and hypoxia. EACR 2023: Innovative Cancer Science , (Turin, Italy), 481-482.

Ferah, S., Çamlıbel, M., Erçelik, M., Tekin, Ç., Tezcan, G., & Tunca, B., (2023). Fisetin additively affects the Temozolomide response of Glioblastoma cells under normoxia and hypoxia . EACR 2023: Innovative Cancer Science (pp.481-482). Turin, Italy

Ferah, Sena Et Al. "Fisetin additively affects the Temozolomide response of Glioblastoma cells under normoxia and hypoxia," EACR 2023: Innovative Cancer Science, Turin, Italy, 2023

Ferah, Sena Et Al. "Fisetin additively affects the Temozolomide response of Glioblastoma cells under normoxia and hypoxia." EACR 2023: Innovative Cancer Science , Turin, Italy, pp.481-482, 2023

Ferah, S. Et Al. (2023) . "Fisetin additively affects the Temozolomide response of Glioblastoma cells under normoxia and hypoxia." EACR 2023: Innovative Cancer Science , Turin, Italy, pp.481-482.

@conferencepaper{conferencepaper, author={Sena Ferah Et Al. }, title={Fisetin additively affects the Temozolomide response of Glioblastoma cells under normoxia and hypoxia}, congress name={EACR 2023: Innovative Cancer Science}, city={Turin}, country={Italy}, year={2023}, pages={481-482} }